Ready, Set, Retina

GA Management: Patient Selection for Complement Inhibition Treatment

15 min · 20 aug 2025
aflevering GA Management: Patient Selection for Complement Inhibition Treatment artwork

Beschrijving

On this episode of Ready, Set, Retina, Daniel Epshtein, OD, FAAO, sits down with Murtaza Adam, MD, to review a case of geographic atrophy (GA) and discuss optimal patient selection for complement inhibition treatments. For the full episode including imaging, head to the article: https://eyesoneyecare.com/resources/ga-management-patient-selection-for-complement-inhibition-treatment Ready Set Retina is independently editorial content supported by advertising from Astellas. The information provided in this article does not and is not intended to constitute medical advice; instead, all information, content, materials available herein are for general information purposes only.

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de Ready, Set, Retina community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

16 afleveringen

aflevering Diabetic Re-Entry Retinopathy: Paul Chous, MA, OD, FAAO & Daniel Epshtein, OD, FAAO artwork

Diabetic Re-Entry Retinopathy: Paul Chous, MA, OD, FAAO & Daniel Epshtein, OD, FAAO

On this episode of Ready, Set, Retina, Daniel Epshtein, OD, FAAO, is joined by A. Paul Chous, MA, OD, FAAO, to discuss a case report of diabetic re-entry retinopathy. Watch the full episode with imaging here: https://eyesoneyecare.com/resources/diabetic-re-entry-retinopathy Ready, Set, Retina is independently editorial content supported by advertising from Apellis Pharmaceuticals. The information provided in this article does not and is not intended to constitute medical advice; instead, all information, content, materials available herein are for general information purposes only. Ready Set Retina is independently editorial content supported by advertising from Astellas. The information provided in this article does not and is not intended to constitute medical advice; instead, all information, content, materials available herein are for general information purposes only.

22 apr 202516 min